- Frontier IP said Friday its portfolio company The Vaccine Group won a £403,000 grant as part of a £1.46m Anglo-Chinese project to combat a disease able to jump from pigs to humans with potentially fatal effect.

The project, funded by the Department of Health and Social Care and administered by Innovate UK, would develop The Vaccine Group’s herpesvirus-based platform technology to create a single-use vaccine for use in pigs.

The vaccine would target a bacterium called Streptococcus suis, which can cause meningitis, blood poisoning, or septicaemia, as well as many other serious diseases in humans, the company said. 'The disease is currently treated with antibiotics, but there is growing evidence that S.suis is becoming resistant to them.'

'The work will be undertaken with Chinese partners, including the Shanghai Veterinary Research Institute at the Chinese Academy of Agricultural Science, and the Shanghai Jiao Tong University,' it added.

At 9:34am: [LON:FIPP] Frontier IP Group PLC share price was +1.5p at 83p

Story provided by